Mualliflar

  • Онгарбайев Д.О.

##semicolon##

ўпка туберкулёзи, рецидив, прогнозлаш, хавф омиллари, клиник кўрсаткичлар, иммунологик маркерлар, ген полиморфизми, цитокинлар, Toll-симон рецепторлар, прогностик модель, стратификация.

##submission.citations##

1. Alene K.A., Viney K., Gray D.J., McBryde E.S., Xu Z., Clements A.C.A. Development of a Risk Score for Prediction of Poor Treatment Outcomes among Patients with Multidrug-Resistant Tuberculosis // PLOS ONE. – 2020. – Vol. 15, № 1. – P. 0227100. – DOI: https://doi.org/10.1371/journal.pone.022710

2. Alliluev A.S., Filinyuk O.V., Shnayder E.E., Aksenov S.V. Machine Learning for Prediction of Relapses in Multiple Drug Resistant Tuberculosis Patients // Tuberculosis and Lung Diseases. – 2021. – Vol. 99, № 11. – P. 27–34. – DOI: https://doi.org/10. 21292/2075-1230-2021-99-11-27-34.

3. Babushkina N.P., Bragina E.Yu. Expression studies of tuberculosis susceptibility genes // Russian Journal of Infection and Immunity. – 2020. – Vol. 11, № 2. – P. 209–222. – DOI: https://doi.org/10. 15789/2220-7619-ESO-1289.

4. Cox S.R., Moe A.H., Gupte A.N. et al. A Point-of-Care Prediction Tool for Recurrent Tuberculosis // Clinical Infectious Diseases. – 2025. – Vol. 81, № 6. – P. 612–622. – DOI: https://doi.org/10.1093/cid/ ciaf353.

5. Darboe F., Mbandi S.K., Naidoo K. et al. Detection of Tuberculosis Recurrence, Diagnosis and Treatment Response by a Blood Transcriptomic Risk Signature in HIV-Infected Persons on Antiretroviral Therapy // Frontiers in Microbiology. – 2019. – Vol. 10. – DOI: https://doi.org/10.3389/fmicb.2019.01 441.

6. Gupte A., Kumar P., Araújo-Pereir M. et al. Baseline IL-6 Is a Biomarker for Unfavourable Tuberculosis Treatment Outcomes: A Multisite Discovery and Validation Study // European Respiratory Journal. – 2022. – Vol. 59, № 4. – P. 2100905. – DOI: https://doi.org/10.1183/13993003.00905-2021.

7. Moons K.G.M., Altman D.G., Reitsma J.B. et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration. Translation in to Russian // Digital Diagnostics. – 2022. – Vol. 3, № 3. – P. 232–322. – DOI: https://doi.org/10.17816/ DD110794.

8. Salamaikina S., Kulabukhova E., Korchagin V., Khokhlova O., Mironov K., Akimkin V. Toll-Like Receptor Genes and Risk of Latent Tuberculosis Infection in People Infected with HIV-1 // Viruses. – 2024. – Vol. 16, № 9. – P. 1371. – DOI: https://doi.org /10.3390/v16091371.

9. Sivakumaran D., Jenum S., Vaz M. et al. Combining Host-Derived Biomarkers with Patient Characteristics Improves Signature Performance in Predicting Tuberculosis Treatment Outcomes // Communications Biology. – 2020. – Vol. 3, № 1. – P. 359. – DOI: https://doi.org/10.1038/s42003-020-1087-x.

10. Алыменко М.А., Воронцова М.В., Балобанова Н.П. и др. Соотношение IFN-γ/IL-10 как показатель эффективности лечения больных туберкулезом легких // ВИЧ-инфекция и иммуносупрессии. – 2025. – Т. 17, № 3. – С. 90–97. – DOI: https://doi.org/10.22328/2077-9828-2025-17-3-90-97.